Ceftriaxone Compared with Cefotaxime for Serious Bacterial Infections

Cefotaxime and ceftriaxone are the preferred parenteral cephalosporins for serious pneumococcal infections in children and adults, but up to 3-5% of strains ...

Comparison of in-vitro Antibiotic Susceptibility of Ciprofloxacin ...

5 On the contrary, Fluoroquinolones, show an excellent activity against gram negative bacteria when compared to gram positive bacteria. Further, ...

Piperacillin + tazobactam - Essential Medicines List

In a systematic review and meta-analysis comparing ertapenem with ceftriaxone (8 RCTs; 2883 patients), similar clinical success was reported (OR 1.13; 95% CI ...

NG240 Meningitis (bacterial) and meningococcal disease - NICE

Two studies compared meropenem to a cephalosporin [cefotaxime or ceftriaxone. (Schmutzhard 1995); cefotaxime plus ampicillin (Brink 2019)].

Meningitis Treatment & Management - Medscape Reference

Cefotaxime – 2 g IV every 4 hours. Ceftriaxone – 2 g IV every 12 hours. Vancomycin – 750-1000 mg IV every 12 hours or 10-15 ...

Antibiotics - EMCrit Project

Urinary tract infection, including pyelonephritis (without severe septic shock). Bacteremia, endocarditis. SBP (spontaneous bacterial ...

Cefotaxime: A Reappraisal in Lower Respiratory Tract Infections.

The updated review article has critical and balanced view of this drug cefotaxime and has been compared to its biggest competitor – ceftriaxone on the basis of ...

A multicentre clinical study on the injection of ceftriaxone/sulbactam ...

Ceftriaxone/sulbactam is as effective and well-tolerated as cefoperazone/sulbactam for the treatment of intermediate and severe bacterial infections caused by ...

Ceftriaxone and cefotaxime use in Victorian hospitals

Most patients (551 [82%]) were given CEFX for empirical treatment of infection; 99 (15%) were given CEFX for surgical prophylaxis of infection; ...

Study raises questions about efficacy of antibiotics for serious ...

... serious bacterial infections and rising antimicrobial resistance (AMR). ... ceftriaxone and cefotaxime—are becoming ... ceftriaxone/cefotaxime ...

Different Generations of Cephalosporin Medication - Verywell Health

Finally, cefepime has gram-positive coverage comparable with ceftriaxone. Here are some clinical uses for cefepime: Moderate to severe pneumonia ...

A multicentre clinical study on the injection of ceftriaxone/sulbactam ...

Ceftriaxone/sulbactam is as effective and well-tolerated as cefoperazone/sulbactam for the treatment of intermediate and severe bacterial ...

NG240 Meningitis (bacterial) and meningococcal disease - NICE

• Amoxicillin or ampicillin plus cefotaxime or ceftriaxone vs cefotaxime or ceftriaxone alone. In cases of severe beta-lactam allergy:.

Ceftriaxone versus ampicillin for the treatment of community ...

Ampicillin was associated with comparable clinical outcomes in comparison to ceftriaxone for patients who were hospitalized due to CAP.

Ceftriaxone - Wikipedia

Ceftriaxone, sold under the brand name Rocephin, is a third-generation cephalosporin antibiotic used for the treatment of a number of bacterial infections.

Cefotaxime Injection: MedlinePlus Drug Information

It works by killing bacteria. Antibiotics such as cefotaxime injection will not work for colds, flu, or other viral infections. Using ...

Gonococcal Infections Among Adolescents and Adults - CDC

* For persons weighing ≥150 kg, 1 g ceftriaxone should be administered. If chlamydial infection is identified when pharyngeal gonorrhea testing is performed, ...

OCCURRENCE OF HYPERBILIRUBINEMIA IN NEONATES GIVEN ...

Conclusion: In present study we had observed hyperbilirubinemia in patients received both ceftriaxone and cefotaxime. However cefotaxime ...

Intravenous-to-Oral Switch Therapy - Medscape Reference

Clindamycin (Cleocin) is a lincosamide used to treat serious skin and soft tissue staphylococcal infections. It is also effective against ...

Ceftriaxone Workshop: Overview and Conclusion

Bacterial infections caused 3 deaths in the ceftriaxone group and 5 deaths in the cefotaxime group. The systemic tolerance of both regimens was excellent.